1 / 26

UK Focal Point on Drugs

The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager. UK Focal Point on Drugs. Jointly based at the Department of Health and the North West Public Health Observatory, Liverpool John Moores University. One of 30 Focal Points across Europe.

dorothy-nicholson
Download Presentation

UK Focal Point on Drugs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The UK Drugs Situation:Data, information and usesCharlotte Davies, UK Focal Point Project Manager

  2. UK Focal Point on Drugs • Jointly based at the Department of Health and the North West Public Health Observatory, Liverpool John Moores University. • One of 30 Focal Points across Europe. • Statutory requirement to provide data and information to the European Monitoring Centre on Drugs and Drug Addiction (EMCDDA). • Covers the whole of the United Kingdom. • Work with a wide range of partners including government departments, devolved administrations, and academics.

  3. UK Focal Point on Drugs’ partners

  4. 5 KEY EPIDEMIOLOGICAL INDICATORS

  5. General population surveys Adults (16-59/64) – household surveys usually crime surveys Children (11-15) – school surveys Lifetime; last year; last month Frequency of use

  6. Problem drug use EMCDDA definition: Injecting drug use or long-duration/regular use of opioids, cocaine and/or amphetamines

  7. Problem drug use * Wales

  8. Treatment Demand Indicator

  9. Drug-related infectious diseases • Report on prevalence of HIV, HCV and HBc from surveys of injecting drug users • Also report notifications data • Behavioural data EUROPE – HCV prevalence ranges from 22% to 83%

  10. Drug-related deaths Wales – 43.6

  11. Supply indicators • Drug offences data • Drug seizures data • Price data • Purity data • Composition of illicit tablets

  12. UK Focal Point outputs Statistical tables Annual Report on the UK drug situation

  13. ANNUAL REPORT ON THE UK DRUG SITUATION

  14. Annual Report chapters • Drug policy: legislation, strategies and economic analysis • Drug use in the general population and specific groups • Prevention • Problem drug use • Drug-related treatment: treatment demand and treatment availability • Health correlates and consequences • Responses to health correlates and consequences • Social correlates and consequences • Drug-related crime, prevention of drug-related crime and prison • Drug markets

  15. Other data and information • Drug-related government expenditure • All govt. depts., devolved administrations • Hospital statistics • Responsible health organisation. UK figure • Needle and syringe exchange data • Scotland, Wales and Northern Ireland • Rates of reoffending and community sentence completions • Published data and administrative data from MoJ

  16. Other data and information • Sentencing statistics • Published data, extra analysis by primary drug • Results from published studies • Summaries of government, charity and academic reports • Summaries of UK drug-related journal articles • Peer reviewed journals, summaries including study methodology and findings Register of research – available on UK Focal Point website

  17. Selected issue chapters Drug users with children Mortality related to drug use History, methods and implementation of national drug treatment guidelines Drug-related health policies and services in prison Treatment and care of older drug users Residential treatment for drug users Costs of drug-related treatment Trends in injecting drug use

  18. HOW ARE THE DATA AND INFORMATION USED BY THE EMCDDA?

  19. EMCDDA’s Annual Report and Statistical Bulletin Annual Report Statistical Bulletin Selected Issues www.emcdda.europa.eu

  20. European Database on Demand Reduction Activities (EDDRA) Searchable database of evaluated interventions Quality of the evaluation is graded UK adds entries annually

  21. European Database on Demand Reduction Activities (EDDRA) Evaluation of All Wales School Liaison programme Evaluation of the take-home naloxone pilot in Wales Blueprint evaluation Evaluation of Option 2 Evaluation of Positive Futures

  22. Early Warning System Forensic agencies Hospital toxicologists Special mortality registers Law enforcement UK Early Warning System EMCDDA’s Early Warning System

  23. HOW IS THE DATA AND INFORMATION USEFUL?

  24. INFORMATION FOR ACTION • One-stop shop for drug-related information • Health, social care and criminal justice • Unique UK perspective • Allows comparisons between constituent countries • Information on best practice when designing interventions • EDDRA, research summaries within Annual Report • Provide link to Europe • Request information from other EU countries

  25. DATA SOURCES First point of call when looking for UK drugs data and information 2012 Information Map Project – create a resource mapping all sources of UK drugs data and make this publicly available

  26. CONTACTS WWW.UKFOCALPOINT.ORG.UK charlotte.davies@dh.gsi.gov.uk TO JOIN OUR MAILING LIST FOR UK FOCAL POINT AND EMCDDA PRODUCTS, PLEASE SIGN UP ON OUR STAND OR EMAIL: ukfocalpoint@dh.gsi.gov.uk

More Related